Investec Bank Plc has filed an amended Form 8.5 disclosure relating to dealings in the ordinary shares of Advanced Medical Solutions Group Plc (AMS.L).
The disclosure, made under Rule 8.5 of the Takeover Code, identifies Investec as an exempt principal trader acting in a client-serving capacity with recognised intermediary status.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status in relation to the offer.
The dealings covered by the amended disclosure were undertaken on 18th September 2026, with the amendment itself published on 21st September 2026.
During the relevant period, Investec purchased 35,703 ordinary shares in Advanced Medical Solutions Group Plc at prices ranging between 281.5p and 282p per unit.
On the sales side, Investec recorded significantly larger activity, selling a total of 515,471 ordinary shares at prices also ranging between 281.5p and 282p per unit.
No cash-settled derivative transactions were reported as part of this disclosure, with those sections of the form returning not applicable across all fields.
Similarly, no stock-settled derivative transactions, including options, were written, purchased, sold, or exercised during the period covered by the amended filing.
Investec confirmed there are no indemnity or other dealing arrangements that may constitute an inducement to deal or refrain from dealing in relation to any party to the offer.
The bank also confirmed no agreements, arrangements, or understandings exist relating to voting rights or future acquisition or disposal of relevant securities to which any derivative is referenced.
The contact named on the disclosure is Priyali Bhattacharjee, reachable by telephone for regulatory enquiries related to this filing.
Public disclosures under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service in accordance with standard market transparency obligations.
